Transcriptomic analysis of AMPK and HZL-1 mutants reveals widespread gene expression differences predominantly in the germ line. by Sabih Rashid (5618807)

Two-Photon imaging of uncleared ITTs from marmoset testis. by Pauline Wanjiku Kibui (22806184)

Analysis of DCX⁺ cells showing migratory morphology (cells with small, oval/fusiform cell soma – less than 9 µm – and an unbranched leading process) in the amygdala of a... by Marco Ghibaudi (16701750)

Observed richness for each substrate over the course of four transfers performed bi-weekly. by Laura G. Schaerer (12025435)

This is the raw data used for this study. by James M. Friedman (22522150)

“…Occipital headaches decreased from 66% to 6%. Rotator cuff impingement decreased from 87% to 10%. …”

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

“…Occipital headaches decreased from 66% to 6%. Rotator cuff impingement decreased from 87% to 10%. …”

Patient Demographics. by James M. Friedman (22522150)

“…Occipital headaches decreased from 66% to 6%. Rotator cuff impingement decreased from 87% to 10%. …”

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

“…Occipital headaches decreased from 66% to 6%. Rotator cuff impingement decreased from 87% to 10%. …”

Canopy effects from biomass utilization on the Priest River Experimental Forest by Ina S. Miller (19658593)

“…To explore these objectives, we installed research sites at several locations and studied management at the small plot scale. The Priest River Experimental Forest (PREF) which is in the northern panhandle of Idaho approximately 12 kilometers (km) (7 miles (mi)) northeast of Priest River, Idaho, was chosen as one research study area because biomass removal projects had been completed in years past. …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…Phosphenium pincer complexes have emerged as promising alternatives to transition metal catalysts for small-molecule activation. Among them, only the 2,6-bis(o-carborano)pyridine-stabilized phosphenium cation (<b>1</b>^<b>+</b>) has been shown to activate molecular hydrogen (H₂). …”

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates by Evan C. Chen (15054014)

Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

“…This study develops a small-molecule NIR-II phototherapeutic agent (IRF) with a high fluorescence quantum yield (17.4%), excellent PCE (96.8%) for photothermal therapy (PTT), and photodynamic therapy (PDT) activity. …”